These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7424824)

  • 1. Extension of myeloid tissue into the lower extremities in polycythemia.
    Kurnick JE; Mahmood T; Napoli N; Block MH
    Am J Clin Pathol; 1980 Oct; 74(4):427-31. PubMed ID: 7424824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marrow biopsy and survival in multiple myeloma.
    Mahmoud LA; Block MH; Franks JJ; Sayed NM
    Am J Clin Pathol; 1983 Sep; 80(3):363-9. PubMed ID: 6881100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of bone marrow morphology for the diagnosis of polycythaemia vera.
    Lundin PM; Ridell B; Weinfeld A
    Scand J Haematol; 1972; 9(3):271-82. PubMed ID: 4507076
    [No Abstract]   [Full Text] [Related]  

  • 4. Polycythemia vera. I. Histopathology, ultrastructure and cytogenetics of the bone marrow in comparison with secondary polycythemia.
    Vykoupil KF; Thiele J; Stangel W; Krmpotic E; Georgii A
    Virchows Arch A Pathol Anat Histol; 1980; 389(3):307-24. PubMed ID: 7456327
    [No Abstract]   [Full Text] [Related]  

  • 5. Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.
    Vytrva N; Stacher E; Regitnig P; Zinke-Cerwenka W; Hojas S; Hubmann E; Porwit A; Bjorkholm M; Hoefler G; Beham-Schmid C
    Arch Pathol Lab Med; 2014 Sep; 138(9):1203-9. PubMed ID: 25171702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of bone marrow histology in differentiating between early stage Polycythemia vera and secondary (reactive) Polycythemias.
    Thiele J; Kvasnicka HM; Zankovich R; Diehl V
    Haematologica; 2001 Apr; 86(4):368-74. PubMed ID: 11325641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary (essential) thrombocythemia versus polycythemia vera rubra. A histomorphometric analysis of bone marrow features in trephine biopsies.
    Thiele J; Zankovich R; Schneider G; Kremer B; Fischer R; Diehl V
    Anal Quant Cytol Histol; 1988 Oct; 10(5):375-82. PubMed ID: 3207462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Minimally Invasive Cancellous Bone Graft Harvesting in Trauma Indication - Experimental Part of the Study].
    Látal P; Štiková Z; Tříska Z; Šperl J; Kloub M
    Acta Chir Orthop Traumatol Cech; 2020; 87(1):48-51. PubMed ID: 32131971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of polycythemia vera based on bone marrow pathology.
    Thiele JM; Kvasnicka HM
    Curr Hematol Rep; 2005 May; 4(3):218-23. PubMed ID: 15865875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic impact of bone marrow histopathology in polycythemia vera (PV).
    Thiele J; Kvasnicka HM
    Histol Histopathol; 2005 Jan; 20(1):317-28. PubMed ID: 15578448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycythemia vera and myelofibrosis: correlation of MR imaging, clinical, and laboratory findings.
    Kaplan KR; Mitchell DG; Steiner RM; Murphy S; Vinitski S; Rao VM; Burk DL; Rifkin MD
    Radiology; 1992 May; 183(2):329-34. PubMed ID: 1561331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group.
    Michiels JJ; Juvonen E
    Semin Thromb Hemost; 1997; 23(4):339-47. PubMed ID: 9263350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localized in vivo proton spectroscopy of the bone marrow in patients with leukemia.
    Jensen KE; Jensen M; Grundtvig P; Thomsen C; Karle H; Henriksen O
    Magn Reson Imaging; 1990; 8(6):779-89. PubMed ID: 2266805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polycythemia rubra vera versus secondary polycythemias. A clinicopathological evaluation of distinctive features in 199 patients.
    Thiele J; Kvasnicka HM; Muehlhausen K; Walter S; Zankovich R; Diehl V
    Pathol Res Pract; 2001; 197(2):77-84. PubMed ID: 11261821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Histologic bone marrow findings in polycythemia vera before and after P32 therapy. (At the same time a contribution to the differential diagnosis of the clinical feature "polycythemia")].
    Hauswaldt C; Hunstein W; Uhl N; Doering P
    Arch Klin Med; 1967; 213(3):219-36. PubMed ID: 5594424
    [No Abstract]   [Full Text] [Related]  

  • 16. Contribution of bone marrow biopsy in the diagnosis and prognosis of polycythemia vera.
    de Mascarel A
    Nouv Rev Fr Hematol (1978); 1994 Apr; 36(2):165-6. PubMed ID: 8036134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Presence of lymphatic nodules in the bone marrow of subjects with polycythemia vera and secondary polyglobulism].
    Navone R; Valpreda M
    Pathologica; 1983; 75(1036):235-40. PubMed ID: 6634233
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytogenetic studies in polycythemia vera.
    Jarosová M; Indrák K; Dusek J; Kapustová M
    Neoplasma; 1988; 35(2):221-8. PubMed ID: 3374710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The bone marrow in polycythemia vera.
    Ellis JT; Peterson P
    Pathol Annu; 1979; 14 Pt 1():383-403. PubMed ID: 390480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of beta-catenin in chronic myeloproliferative disorders.
    Jauregui MP; Sanchez SR; Ewton AA; Rice L; Perkins SL; Dunphy CH; Chang CC
    Hum Pathol; 2008 Oct; 39(10):1454-8. PubMed ID: 18619646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.